Abstract
Commentary to:
19-nor-1α,25-Dihydroxyvitamin D2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo
Gary G. Schwartz, Dawn Eads, Christine Naczki, Scott Northrup, Tai Chen, Constantinos Koumenis
Advanced search
Go to submission site
We're pleased that you plan to submit your article! Before starting your submission, please check that this journal's publishing policy is compatible with your and your co-authors' funding agreements. Taylor & Francis requires you to delay making an Accepted Manuscript version of your article available if you are not publishing Open Access.
Cancer Biology & Therapy
Volume 7, 2008 - Issue 3
191
Views
7
CrossRef citations to date
0
Altmetric
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
![Publish Open Access Finland]({"type":"image" , "src" : "/sda/110396/JournalAd-OA-Agreements.gif"})
![Annals of medicine, now fully Open Access!]({"type":"image" , "src" : "/sda/110649/IANN-Dermatology.gif"})
Commentary
Vitamin D for the treatment and prevention of pancreatic cancer.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.